Aleksander Krag

23.8k total citations · 7 hit papers
232 papers, 8.7k citations indexed

About

Aleksander Krag is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Aleksander Krag has authored 232 papers receiving a total of 8.7k indexed citations (citations by other indexed papers that have themselves been cited), including 174 papers in Epidemiology, 137 papers in Hepatology and 45 papers in Surgery. Recurrent topics in Aleksander Krag's work include Liver Disease Diagnosis and Treatment (162 papers), Liver Disease and Transplantation (117 papers) and Alcohol Consumption and Health Effects (41 papers). Aleksander Krag is often cited by papers focused on Liver Disease Diagnosis and Treatment (162 papers), Liver Disease and Transplantation (117 papers) and Alcohol Consumption and Health Effects (41 papers). Aleksander Krag collaborates with scholars based in Denmark, Germany and United States. Aleksander Krag's co-authors include Lise Lotte Gluud, Jonel Trebicka, Flemming Bendtsen, Søren Møller, Pere Ginès, Paolo Angeli, Maja Thiele, Claire Francoz, Rajeshwar P. Mookerjee and Wim Laleman and has published in prestigious journals such as Nature, The Lancet and Nature Medicine.

In The Last Decade

Aleksander Krag

218 papers receiving 8.5k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis

2018 1.8k citations Paolo Angeli, Claire Francoz et al. Journal of Hepatology profile →
Low Accuracy of FIB-4 and NAFLD Fibrosis Scores for Screening for Liver Fibrosis in the Population

2021 171 citations Maja Thiele, Guruprasad P. Aithal et al. profile →
Noninvasive proteomic biomarkers for alcohol-related liver disease

2022 154 citations Maja Thiele, Ditlev Nytoft Rasmussen et al. Nature Medicine profile →
EASL Clinical Practice Guidelines on acute-on-chronic liver failure

2023 134 citations Richard Moreau, Marta Tonon et al. Journal of Hepatology profile →
Using the ELF test, FIB-4 and NAFLD fibrosis score to screen the population for liver disease

2023 116 citations Maria Kjærgaard, Katrine Prier Lindvig et al. Journal of Hepatology profile →
Steatotic liver disease

2024 95 citations Mads Israelsen, Aleksander Krag et al. profile →
Validation of the new nomenclature of steatotic liver disease in patients with a history of excessive alcohol intake: an analysis of data from a prospective cohort study

2024 75 citations Mads Israelsen, Nikolaj Torp et al. profile →

Peers

Countries citing papers authored by Aleksander Krag

Since Specialization

Citations

This map shows the geographic impact of Aleksander Krag's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aleksander Krag with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aleksander Krag more than expected).

Fields of papers citing papers by Aleksander Krag

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aleksander Krag. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aleksander Krag. The network helps show where Aleksander Krag may publish in the future.

Co-authorship network of co-authors of Aleksander Krag

This figure shows the co-authorship network connecting the top 25 collaborators of Aleksander Krag. A scholar is included among the top collaborators of Aleksander Krag based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aleksander Krag. Aleksander Krag is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	PNPLA3 and TM6SF2 exacerbate the impact of alcohol and metabolic dysfunction on liver fibrosis 2025 ·JHEP Reports ·(unknown), (unknown), (unknown), Camilla Dalby Hansen, Lorenz Balcar, K. Bech, (unknown), Nikolaj Torp, Bernhard Wernly, (unknown), (unknown), Christian Datz, Michael Straßer, Mads Israelsen, (unknown), Torben Hansen, Aleksander Krag, Elmar Aigner, Maja Thiele, Georg Semmler	0
2	Albumin infusion in hepatorenal syndrome-acute kidney injury: New evidence challenges recent consensus 2025 ·Journal of Hepatology ·Paolo Angeli, Christian Labenz, Salvatore Piano, Adrià Juanola, Aleksander Krag, Paolo Caraceni, Jonel Trebicka, (unknown), Virendra Singh, Elisa Pose, Carmine Gambino, Sebastián Marciano, Peter R. Galle, Shiv Kumar Sarin, Pere Ginès, Patrick S. Kamath	3
3	Ability of soluble TREM2 and PRO-C3 as biomarkers to predict changes in MASLD activity 2025 ·JHEP Reports ·Charlotte Wilhelmina Wernberg, Vineesh Indira Chandran, Mette Munk Lauridsen, (unknown), Camilla Dalby Hansen, Johanne Kragh Hansen, Lea Ladegaard Grønkjær, (unknown), (unknown), Sönke Detlefsen, Maja Thiele, (unknown), Ida Falk Villesen, Diana Julie Leeming, M.A. Karsdal, Jonas Heilskov Graversen, Aleksander Krag	3
4	Personalised human albumin in patients with cirrhosis and ascites: design and rationale for the ALB-TRIAL - a randomised clinical biomarker validation trial 2024 ·BMJ Open ·Nikolaj Torp, Mads Israelsen, Minneke J. Coenraad, Mária Papp, Debbie L. Shawcross, Marko Korenjak, Paolo Angeli, Wim Laleman, Adrià Juanola, Pere Ginès, Jonel Trebicka, Aleksander Krag	6
5	Lipid profiling identifies modifiable signatures of cardiometabolic risk in children and adolescents with obesity 2024 ·Nature Medicine ·Yun Huang, Karolina Sulek, Sara Stinson, Louise Aas Holm, Min Kim, Kajetan Trôst, (unknown), Morten Asp Vonsild Lund, Cilius Esmann Fonvig, Helene Bæk Juel, Trine Nielsen, Lars Ängquist, Peter Rossing, Maja Thiele, Aleksander Krag, Jens‐Christian Holm, Cristina Legido‐Quigley, Torben Hansen	21
6	Using liver stiffness to predict and monitor the risk of decompensation and mortality in patients with alcohol-related liver disease 2024 ·Journal of Hepatology ·Katrine Holtz Thorhauge, Georg Semmler, Stine Johansen, Katrine Prier Lindvig, Maria Kjærgaard, Johanne Kragh Hansen, Nikolaj Torp, Camilla Dalby Hansen, Peter Andersen, Benedikt Hofer, Wen Gu, Mads Israelsen, Mattias Mandorfer, Thomas Reiberger, Jonel Trebicka, Maja Thiele, Aleksander Krag	20
7	Binge drinking episode causes acute, specific alterations in systemic and hepatic inflammation‐related markers 2023 ·Liver International ·Evelina Stankevič, Mads Israelsen, Helene Bæk Juel, (unknown), Lars Ängquist, Peter Aldiss, Nikolaj Torp, Stine Johansen, Camilla Dalby Hansen, Johanne Kragh Hansen, Katrine Holtz Thorhauge, Katrine Prier Lindvig, Bjørn Stæhr Madsen, Karolina Sulek, Cristina Legido‐Quigley, Maja Thiele, Aleksander Krag, Torben Hansen	15
8	A six-month low-carbohydrate diet high in fat does not adversely affect endothelial function or markers of low-grade inflammation in patients with type 2 diabetes: an open-label randomized controlled trial 2023 ·Cardiovascular Diabetology ·Eva-Marie Gram-Kampmann, Thomas Bastholm Olesen, Camilla Dalby Hansen, (unknown), Jane Møller Jensen, Aase Handberg, Henning Beck‐Nielsen, Aleksander Krag, Michael Hecht Olsen, Kurt Højlund	10
9	EASL Clinical Practice Guidelines on acute-on-chronic liver failure breakdown → 2023 ·Journal of Hepatology ·Richard Moreau, Marta Tonon, Aleksander Krag, Paolo Angeli, Marina Berenguer, Annalisa Berzigotti, Javier Fernández, Claire Francoz, Thierry Gustot, Rajiv Jalan, Mária Papp, Jonel Trebicka	134
10	Extra‐hepatic morbidity and mortality in alcohol‐related liver disease: Systematic review and meta‐analysis 2023 ·Liver International ·(unknown), Guruprasad P. Aithal, Michael Allison, Mayur Brahmania, Ewan Forrest, Hannes Hagström, Stine Johansen, Aleksander Krag, Alisa Likhitsup, Steven Masson, Anne McCune, Neil Rajoriya, Maja Thiele, Ian Rowe, Richard Parker	16
11	An adult‐based genetic risk score for liver fat associates with liver and plasma lipid traits in children and adolescents 2023 ·Liver International ·Yun Huang, Sara Stinson, Helene Bæk Juel, Morten Asp Vonsild Lund, Louise Aas Holm, Cilius Esmann Fonvig, Trine Nielsen, Niels Grarup, Oluf Pedersen, Michael Christiansen, Elizaveta Chabanova, Henrik S. Thomsen, Aleksander Krag, Stefan Stender, Jens‐Christian Holm, Torben Hansen	3
12	The negative bidirectional interaction between climate change and the prevalence and care of liver disease: A joint BSG, BASL, EASL, and AASLD commentary 2022 ·Journal of Hepatology ·Mhairi Donnelly, William Stableforth, Aleksander Krag, Adrian Reuben	11
13	Closing spontaneous portosystemic shunts in cirrhosis: Does it make sense? Does it work? What does it take? 2022 ·Metabolic Brain Disease ·Wim Laleman, Michael Praktiknjo, Mette Munk Lauridsen, (unknown), (unknown), Chris Verslype, Aleksander Krag, Jonel Trebicka, Geert Maleux	7
14	Binge drinking induces an acute burst of markers of hepatic fibrogenesis (PRO‐C3) 2021 ·Liver International ·Nikolaj Torp, Mads Israelsen, Mette Juul Nielsen, (unknown), (unknown), Stine Johansen, Camilla Dalby Hansen, Bjørn Stæhr Madsen, Ida Falk Villesen, Diana Julie Leeming, Maja Thiele, Torben Hansen, M.A. Karsdal, Aleksander Krag	15
15	Utilizing the gut microbiome in decompensated cirrhosis and acute-on-chronic liver failure 2020 ·Nature Reviews Gastroenterology & Hepatology ·Jonel Trebicka, Peer Bork, Aleksander Krag, Manimozhiyan Arumugam	116
16	Transcriptional Dynamics of Hepatic Sinusoid‐Associated Cells After Liver Injury 2020 ·Hepatology ·(unknown), (unknown), (unknown), (unknown), (unknown), Ronni Nielsen, Susanne Mandrup, Anders Schlosser, Thomas Levin Andersen, Grith Lykke Sørensen, Aleksander Krag, Kedar Nath Natarajan, Sönke Detlefsen, Henrik Dimke, Kim Ravnskjær	72
17	Alcoholic liver disease: A registry view on comorbidities and disease prediction 2020 ·PLoS Computational Biology ·(unknown), Ditlev Nytoft Rasmussen, Aleksander Krag, Søren Brunak, Lars Juhl Jensen	12
18	Internal dysregulation of the renin system in patients with stable liver cirrhosis 2017 ·Scandinavian Journal of Clinical and Laboratory Investigation ·Annette Dam Fialla, Helle C. Thiesson, Peter Bie, Ove B. Schaffalitzky de Muckadell, Aleksander Krag	7
19	Poster Session 2: Advances in Imaging and Noninvasive Markers of Fibrosis; Bile Acids, Cholangiocyte Biology, and Experimental Cholestasis 2015 ·Hepatology ·Maria Kjærgaard, Maja Thiele, Bjørn Stæhr Madsen, Christian Jansen, Jonel Trebicka, Aleksander Krag, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	4
20	Meta‐analysis: the safety and efficacy of vaptans (tolvaptan, satavaptan and lixivaptan) in cirrhosis with ascites or hyponatraemia 2012 ·Alimentary Pharmacology & Therapeutics ·E. Dahl, Lise Lotte Gluud, Nina Kimer, Aleksander Krag	52

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact